Unknown

Dataset Information

Alternative Lengthening of Telomeres in Cancer Confers a Vulnerability to Reactivation of p53 Function.


ABSTRACT: A subset of cancers across multiple histologies with predominantly poor outcomes use the alternative lengthening of telomeres (ALT) mechanism to maintain telomere length, which can be identified with robust biomarkers. ALT has been reported to be prevalent in high-risk neuroblastoma and certain sarcomas, and ALT cancers are a major clinical challenge that lack targeted therapeutic approaches. Here, we found ALT in a variety of pediatric and adult cancer histologies, including carcinomas. Patient-derived ALT cancer cell lines from neuroblastomas, sarcomas, and carcinomas were hypersensitive to the p53 reactivator eprenetapopt (APR-246) relative to telomerase-positive (TA+) models. Constitutive telomere damage signaling in ALT cells activated ataxia-telangiectasia mutated (ATM) kinase to pho

SUBMITTER: Macha SJ 

PROVIDER: S-EPMC9566554 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature